357 related articles for article (PubMed ID: 19505572)
1. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
Chakraborty S; Shukla D; Mishra B; Singh S
Eur J Pharm Biopharm; 2009 Sep; 73(1):1-15. PubMed ID: 19505572
[TBL] [Abstract][Full Text] [Related]
2. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
3. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
4. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
5. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
Pouton CW
Eur J Pharm Sci; 2006 Nov; 29(3-4):278-87. PubMed ID: 16815001
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
Hu L; Tang X; Cui F
J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
O'Driscoll CM; Griffin BT
Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
[TBL] [Abstract][Full Text] [Related]
8. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
9. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
Kohli K; Chopra S; Dhar D; Arora S; Khar RK
Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
[TBL] [Abstract][Full Text] [Related]
10. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
11. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
[TBL] [Abstract][Full Text] [Related]
12. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Müller CE
Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.
Subramanian N; Ghosal SK
Indian J Exp Biol; 2004 Nov; 42(11):1056-65. PubMed ID: 15587110
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS).
Balakrishnan P; Lee BJ; Oh DH; Kim JO; Hong MJ; Jee JP; Kim JA; Yoo BK; Woo JS; Yong CS; Choi HG
Eur J Pharm Biopharm; 2009 Aug; 72(3):539-45. PubMed ID: 19298857
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery.
Di Maio S; Carrier RL
J Control Release; 2011 Apr; 151(2):110-22. PubMed ID: 21134406
[TBL] [Abstract][Full Text] [Related]
16. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
17. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
18. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Biopharm; 2008 Oct; 70(2):439-44. PubMed ID: 18603415
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based formulations for oral administration of poorly water-soluble drugs.
Mu H; Holm R; Müllertz A
Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
[TBL] [Abstract][Full Text] [Related]
20. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
Sek L; Boyd BJ; Charman WN; Porter CJ
J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]